These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 18455143

  • 1. Mycophenolate mofetil for the treatment of uveitis.
    Teoh SC, Hogan AC, Dick AD, Lee RW.
    Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.
    Hogan AC, McAvoy CE, Dick AD, Lee RW.
    Ophthalmology; 2007 May; 114(5):1000-6. PubMed ID: 17467532
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis.
    Rodriguez EE, Sakata VM, Cavalcanti DC, Zaghetto JM, Olivalves E, Hirata CE, Yamamoto JH.
    Arq Bras Oftalmol; 2016 May; 79(6):369-372. PubMed ID: 28076562
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M.
    Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
    [Abstract] [Full Text] [Related]

  • 6. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
    Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 8. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
    Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE.
    Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
    [Abstract] [Full Text] [Related]

  • 9. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K, Varikkara M, Santiago C, Forrester JV.
    Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M, Solanes F, Perez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F.
    J Ocul Pharmacol Ther; 2016 Sep; 32(1):55-61. PubMed ID: 26562247
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil for ocular inflammation.
    Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH.
    Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
    [Abstract] [Full Text] [Related]

  • 13. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M, Stübiger N, Aboalchamat W, Landenberger H, Bialasiewicz AA, Engelmann K.
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [Abstract] [Full Text] [Related]

  • 14. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 15. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM.
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
    Bhat P, Cervantes-Castañeda RA, Doctor PP, Anzaar F, Foster CS.
    Ocul Immunol Inflamm; 2009 Sep; 17(3):185-90. PubMed ID: 19585361
    [Abstract] [Full Text] [Related]

  • 18. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
    Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH, SITE Cohort Research Group.
    Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
    [Abstract] [Full Text] [Related]

  • 19. The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhood.
    Little JA, Sen ES, Strike H, Hinchcliffe A, Guly CM, Lee RW, Dick AD, Ramanan AV.
    J Rheumatol; 2014 Jan; 41(1):136-9. PubMed ID: 24085549
    [Abstract] [Full Text] [Related]

  • 20. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
    Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group.
    JAMA; 2019 Sep 10; 322(10):936-945. PubMed ID: 31503307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.